BiomX Inc.
PHGE
$1.62
$0.074.52%
AMEX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -8.42% | -29.37% | -20.60% | 25.13% | 46.54% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -35.13% | -34.36% | -13.03% | 5.34% | 22.30% |
| Operating Income | 36.07% | 34.36% | 13.03% | -5.34% | -22.30% |
| Income Before Tax | -145.06% | -492.22% | -104.31% | -329.79% | 29.25% |
| Income Tax Expenses | -33.33% | -33.33% | -46.15% | -18.18% | -68.42% |
| Earnings from Continuing Operations | -145.00% | -491.64% | -104.20% | -329.35% | 29.28% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -144.60% | -491.64% | -104.20% | -329.35% | 29.28% |
| EBIT | 36.07% | 34.36% | 13.03% | -5.34% | -22.30% |
| EBITDA | 42.06% | 40.64% | 17.04% | -0.27% | -20.28% |
| EPS Basic | -25.37% | -1,128.98% | 33.90% | 29.67% | 77.11% |
| Normalized Basic EPS | -628.06% | -320.50% | 52.79% | 59.39% | 97.53% |
| EPS Diluted | -15.08% | 51.57% | 73.55% | 67.22% | 85.36% |
| Normalized Diluted EPS | -628.06% | -482.96% | 57.09% | 62.18% | 97.63% |
| Average Basic Shares Outstanding | 234.70% | 114.58% | 133.11% | 203.81% | 267.44% |
| Average Diluted Shares Outstanding | 234.70% | 93.01% | 103.19% | 149.54% | 181.44% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |